Tuesday, June 16, 2026

Suzy Stuns with Striking New Photos as She Promotes Upcoming Digital Single ‘Come Back’

Suzy captivates fans with stunning photos promoting her digital single "Come Back," showcasing her beauty and charm. Release on February 17.

Strengthening the Korea-U.S. Alliance: Key Takeaways from Jang Dong-hyuk’s Washington DC Meetings

Jang Dong-hyuk of the People Power Party discusses U.S.-South Korea relations and security strategies during his D.C. visit.

Trump’s New Tariff Strategy: How Will It Impact EV and Battery Imports in 2026?

Trump plans to expand tariffs on imports deemed national security threats, following a Supreme Court ruling on intergovernmental tariffs.

Kyo Woon Koo

Onconic Therapeutics Expands Zaqbo Development in China With Phase 3 Trial for H. pylori Eradication

Onconic Therapeutics' Zaqbo enters Phase 3 trials in China for H. pylori eradication, with strong revenue growth reported.

Seoul St. Mary’s Hospital Performs Korea’s First Single-Port Robotic Surgery for Plantar Hyperhidrosis

Seoul St. Mary's Hospital successfully performed Korea's first robotic surgery for plantar hyperhidrosis using a single-port robotic platform.

Seoul St. Mary’s Prof. Jang Ki-yuk Selected as Sole Applied Medicine Researcher in National Leader Program

Prof. Jang Ki-yuk of Seoul St. Mary's Hospital receives $5.2M for cardiovascular disease research, focusing on plaque regression.

Daewoong Pharmaceutical Gains Mexico Approval for Type 2 Diabetes Drug as Latin America Expansion Accelerates

Daewoong Pharmaceutical's type 2 diabetes drug Enblo has received approval in Mexico, a key market in Latin America.

Sillajen Presents Early BAL0891 Clinical Findings at ASCO 2026, Highlighting Safety and Early Anti-Cancer Activity

ShillaGen presented initial clinical research results of its cancer drug BAL0891 at ASCO, showcasing promising developments.

Inventage Lab Showcases Next-Generation Monthly Obesity Injection Data Ahead of Global Experts at ADA

Inventage Lab presents its next-gen obesity treatment, reducing dosage frequency from weekly to monthly, to U.S. experts.

Celltrion Expands AI Integration Strategy to Strengthen Global Pharmaceutical Competitiveness

Celltrion is enhancing its global competitiveness by integrating AI into drug development, manufacturing, and administration.

HLB Genex Advances U.S. Market Entry With First Catalase Supply for Semiconductor Manufacturing

HLB Genex has launched catalase shipments to the U.S. semiconductor market, aiming for long-term growth and capitalizing on global demand.

Study Outlines Clinical Potential of Rejuvenating Retinal Cells to Treat Age-Related Vision Loss

Researchers reveal a breakthrough in treating eye diseases by rejuvenating aged cells, potentially restoring vision through epigenetic reprogramming.

Samsung Medical Center Develops AI Technology to Predict Gallbladder Cancer Recurrence and Survival

Samsung Medical Center's AI technology predicts gallbladder cancer prognosis, aiding personalized treatment and improving patient outcomes.

AriBio Advances Global Alzheimer’s Strategy With Multibillion-Dollar AR1001 Licensing Deal

AriBio secures a $4.67 billion licensing deal for Alzheimer's drug AR1001 with Puxing Pharmaceutical, aiming for global commercialization.

Gene Editing Study Suggests New Treatment Path for Rare Krabbe Disease

A study reveals adenine base editing may treat Krabbe disease, offering hope for rare genetic disorders through precise gene correction.

Samsung Medical Center Develops New Score to Identify Early Colorectal Cancer Patients Who May Avoid Additional Surgery

New criteria developed to assess the need for surgery in early-stage colorectal cancer patients after endoscopic resection.

Wontech Secures 75 Billion KRW to Expand Oligio Into Home Beauty and Medical Cosmetics

Wontech secures 750 billion KRW to shift to B2C, launching home beauty devices and expanding its Oligio brand globally.

Top News

- Our Sponsors Ad -

Follow us